FIDSON HEALTHCARE : DECLARATION OF DIVIDEND AND ISSUANCE OF BONUS SHARES
July 08, 2022 at 05:54 am EDT
Share
Fidson Healthcare Plc
Fidson Healthcare Plc hereby announce as follows:
Period Ended
31 December 2021
A Final Dividend of 50 kobo per 50 kobo ordinary share payable to shareholders
whose names appear in the Register of Members as at the close of business on
Proposed Dividend
8th July, 2022.
One (1) for Ten (10) to shareholders whose names appear in the Register of
Proposed Bonus
Members as at the close of business on 8h July, 2022.
The Register of Shareholders will be closed from 11th July, 2022 to 15th July,
Closure of Register
2022 both days inclusive.
Qualification Date
8th July, 2022
On 29th July, 2022, dividends will be paid electronically to shareholders whose
names appear on the Register of Members as at 8th July, 2022, and who have
completed the e-dividend registration and mandated the Registrar to pay their
Payment Date
dividends directly into their Bank accounts.
E-Dividend
Shareholders who are yet to complete the e-dividend registration are advised
Registration
to download the Registrar's E-DividendMandate Activation Form, which is
also available on their website: Error! Hyperlink reference not valid.
Unclaimed Dividend
Shareholders with dividend warrants and share certificates that have remained
Warrants and Share
unclaimed, or are yet to be presented for payment or returned for validation are
Certificates
advised to complete the e-dividend registration or contact the Registrar.
The Company's Annual General Meeting will be held on 28th July, 2022 at
Date of General
10.00 am at the Company's Conference Centre, 2nd Floor, Fidson Towers, 268,
Meeting
Ikorodu Road, Obanikoro, Lagos.
Meristem Registrars and Probate Services Limited, 213 Herbert Macaulay
Registrar
Way, Adekunle Yaba, lagos
Further information may be directed to Yomi Adebanjo Yomi Adebanjo
Investor Relations
yomiadebanjo@fidson.com
Dated this 8th day of July 2022
Signed:
Yomi Adebanjo
Company Secretary
Attachments
Original Link
Original Document
Permalink
Disclaimer
Fidson Healthcare plc published this content on 08 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 July 2022 09:53:07 UTC.
Fidson Healthcare specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of infectious, inflammatory, endocrinal, gastrointestinal, immune, metabolic, cardiovascular, oncological and central nervous system disorders. Net sales break down by activity as follows:
- sale of prescription medicines (70.7%) ;
- sale of OTC products (29.3%).